Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
JAMA Network Open|June 7, 2024
Validation of a Handheld 6-Lead Device for QT Interval Monitoring in Resource-Limited SettingsJohn Z Metcalfe, Tamsin Economou, Fahd Naufal, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 18, 2024
Validation and application of an online extraction and liquid chromatography tandem mass spectrometry assay for the analysis of delamanid and its DM-6705 metabolite in human breast milkBuyisile Mkhize, Richard Court, Sandra Castel, et al.
Tropical Medicine & International Health : TM & IH|November 19, 2016
Tenofovir stock shortages have limited impact on clinic- and patient-level HIV treatment outcomes in public sector clinics in South AfricaAlana T Brennan, Jacob Bor, Mary-Ann Davies, et al.
The Lancet. HIV|March 27, 2025
Tuberculosis disease among people with HIV: therapeutic advancesVidya Mave, Mandar Paradkar, Francesca Conradie, et al.
British Journal of Clinical Pharmacology|December 2, 2025
Population pharmacokinetics of levofloxacin in breastmilk in patients with rifampicin-resistant tuberculosisSharon Sawe, Lufina Tsirizani, Buyisile Mkhize, et al.
Frontiers in Immunology|November 10, 2018
Frequency of Circulating CD4<sup>+</sup>Ki67<sup>+</sup>HLA-DR<sup>-</sup> T Regulatory Cells Prior to Treatment for Multidrug Resistant Tuberculosis Can Differentiate the Severity of Disease and Predict Time to Culture ConversionSelena Ferrian, Melinda Ross, Francesca Conradie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2018
Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological OutcomesMichelle Moorhouse, Gary Maartens, Willem Daniel Francois Venter, et al.
Southern African Journal of HIV Medicine|March 24, 2018
Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infectionLinda-Gail Bekker, Kevin Rebe, Francois Venter, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2025
The effect of pregnancy on the population pharmacokinetics of levofloxacin in South Africans with rifampicin-resistant tuberculosisSharon Sawe, Lufina Tsirizani, Richard Court, et al.
AIDS Research and Human Retroviruses|June 21, 2013
Clinical and pharmacogenetic factors affecting neonatal bilirubinemia following atazanavir treatment of mothers during pregnancyTimothy Eley, Shu-Pang Huang, Francesca Conradie, et al.
Pageof 7